✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Viyash Scientific Ltd.

SEQUENT

Market Cap
₹11,097 Cr.
P/E
62.59

Viyash Scientific Ltd.

  • Viyash Scientific
  • Procter&Gamble Healt
  • Strides Pharma Scien
  • TJI Pharma - Small Cap

FAQs on Viyash Scientific Ltd. Shareprice

Viyash Scientific has given lower returns compared to its competitors.
Viyash Scientific has grown at ~5.9% over the last 10yrs while peers have grown at a median rate of 6.06%

Viyash Scientific is not expensive.
Latest PE of Viyash Scientific is 60.22, while 3 year average PE is 146.
Also latest EV/EBITDA of Viyash Scientific is 23.18 while 3yr average is 152.

View FAQ's On Business

Growth Table

  • Viyash Scientific Ltd.
  • Procter&Gamble Healt
  • Strides Pharma Scien

Balance Sheet

  • Viyash Scientific Ltd.
  • Procter&Gamble Healt
  • Strides Pharma Scien

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Viyash Scientific Ltd.
  • Procter&Gamble Healt
  • Strides Pharma Scien

Cash Flow

  • Viyash Scientific Ltd.
  • Procter&Gamble Healt
  • Strides Pharma Scien

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Viyash Scientific Ltd.
  • Procter&Gamble Healt
  • Strides Pharma Scien

Quarterly Results

  • Viyash Scientific Ltd.
  • Procter&Gamble Healt
  • Strides Pharma Scien

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Viyash Scientific Ltd. Financials

Balance sheet of Viyash Scientific is strong.
But short term working capital might become an issue for this company.

The net debt of Viyash Scientific is decreasing.
Latest net debt of Viyash Scientific is ₹166 Crs as of Mar-26.
This is less than Mar-25 when it was ₹309 Crs.

Yes, profit is increasing.
The profit of Viyash Scientific is ₹152 Crs for TTM, ₹21.88 Crs for Mar 2025 and -₹35.87 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Viyash Scientific latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech